Cassava Sciences Inc (SAVA) Stock Price Today
Overview
Financial
Technicals
Analysis
Corporate Action
About
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Technical Indicators
|
|
|
Bearish (14)
Neutral (7)
Bullish (6)
Performance
SAVA ROI
% from 52W High
52W Low: $9.57
17 Jul 2024
52W High: $35.08
05 Aug 2024
News
People Also Bought
US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions
Let’s trade or invest in this asset by signing up or logging in!
You can also download our app!
